Cancer Research UK
3 clinical trials · 3 recruiting · OTHER
Trials by Cancer Research UK
RECRUITINGPhase 2 / Phase 3NCT05770102
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With...
This clinical trial is looking at a drug called atezolizumab. Atezolizumab is approved as standard of care treatment for adult patients with urothelial cancer, non-small cell lung...
Sponsor: Cancer Research UKEnrolling: 3020 locations
MalignancyMalignant NeoplasmLymphoproliferative Disorders+7
RECRUITINGPhase 2 / Phase 3NCT05770544
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene...
This clinical trial is looking at a drug called entrectinib. Entrectinib is approved as standard of care treatment for adult patients with non-small cell lung cancer (NSCLC) which...
Sponsor: Cancer Research UKEnrolling: 3020 locations
Haematological MalignancyMalignancyMalignant Neoplasm+8
RECRUITINGPhase 1 / Phase 2NCT05944237
HTL0039732 in Participants With Advanced Solid Tumours
The purpose of this trial is to evaluate a new drug, HTL0039732, that will be administered on its own (as a monotherapy) and in combination with atezolizumab or with other...
Sponsor: Cancer Research UKEnrolling: 1505 locations
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11